Insider Trading History of Goldan Keith A.

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Goldan Keith A. since 2015. This trader's CIK number is 1495411. At the time of last reporting, Goldan Keith A. was the Chief Financial Officer of Syndax Pharmaceuticals Inc. (stock ticker symbol SNDX). Also see all insider trading activities at Syndax Pharmaceuticals Inc.

Note that in the past Goldan Keith A. also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Fibrocell Science, Inc. (FCSC) by Goldan Keith A.

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2015 FCSC 2,000 $12,660 0 $0 0 $0

Yearly summary of insider trading at Optinose, Inc. (OPTN) by Goldan Keith A.

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2022 OPTN 0 $0 4,617 $9,741 0 $0
2021 OPTN 0 $0 3,462 $11,594 0 $0
2020 OPTN 2,500 $9,742 0 $0 0 $0

Yearly summary of insider trading at Syndax Pharmaceuticals Inc (SNDX) by Goldan Keith A.

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2025 SNDX 3,000 $0 5,073 $70,591 0 $0
2024 SNDX 1,250 $25,037 0 $0 0 $0
2023 SNDX 0 $0 577 $12,872 0 $0


Insider trading activities at 3 companies by Goldan Keith A.:

1. Fibrocell Science, Inc. (FCSC)

2. Optinose, Inc. (OPTN)

3. Syndax Pharmaceuticals Inc (SNDX)

Table 1. Insider trading of Fibrocell Science, Inc. (FCSC) by Goldan Keith A.

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2015-08-11 FCSC Buy 2,000 6.33 12,660

Table 2. Insider trading of Optinose, Inc. (OPTN) by Goldan Keith A.

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2022-03-16 OPTN Sale 4,617 2.11 9,741
2021-12-16 OPTN Sale 580 1.64 951
2021-09-16 OPTN Sale 578 2.79 1,612
2021-03-15 OPTN Sale 2,304 3.92 9,031
2020-09-23 OPTN Buy 2,500 3.90 9,742

Table 3. Insider trading of Syndax Pharmaceuticals Inc (SNDX) by Goldan Keith A.

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2025-07-16 SNDX Sale 1,296 9.29 12,033
2025-05-19 SNDX Buy 3,000 .00 0
2025-02-10 SNDX Sale 3,777 15.50 58,558
2024-06-14 SNDX Buy 1,250 20.03 25,037
2023-06-13 SNDX Sale 577 22.31 12,872

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Goldan Keith A. (Chief Financial Officer of Syndax Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.